Lusaris Therapeutics

About:

Lusaris Therapeutics develops small-molecule neuroplastogen therapeutics for neuropsychiatric and neurological disorders.

Website: https://lusaristx.com

Twitter/X: LusarisTx

Top Investors: RA Capital Management, Deep Track Capital, Venrock Healthcare Capital Partners, Boxer Capital

Description:

Lusaris is a drug development company that offers neuropsychiatric and neurological therapeutics. The company has a team of experienced drug developers and company builders with extensive neuroscience experience. Lusaris was founded in 2021 and is headquartered in Boston, Massachusetts.

Total Funding Amount:

$60M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2021-11-01

Founders:

Edward Monaghan

Number of Employees:

1-10

Last Funding Date:

2022-11-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai